These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7953196)

  • 41. Degradation of cytochrome P450 2E1: selective loss after labilization of the enzyme.
    Tierney DJ; Haas AL; Koop DR
    Arch Biochem Biophys; 1992 Feb; 293(1):9-16. PubMed ID: 1309987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benzene metabolism by two purified, reconstituted rat hepatic mixed function oxidase systems.
    Chepiga TA; Yang CS; Snyder R
    Adv Exp Med Biol; 1991; 283():261-5. PubMed ID: 2068993
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparative studies on the effect of cadmium, cobalt, lead, and selenium on hepatic microsomal monooxygenase enzymes and glutathione levels in mice.
    Dalvi RR; Robbins TJ
    J Environ Pathol Toxicol; 1978; 1(5):601-7. PubMed ID: 102717
    [No Abstract]   [Full Text] [Related]  

  • 44. Enhancement of hepatic microsomal drug oxidation and glucuronidation in rat by 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT).
    Vainio H
    Chem Biol Interact; 1974 Jul; 9(1):7-14. PubMed ID: 4211984
    [No Abstract]   [Full Text] [Related]  

  • 45. Studies on hydroperoxide-dependent substrate hydroxylation by purified liver microsomal cytochrome P-450.
    Nordblom GD; White RE; Coon MJ
    Arch Biochem Biophys; 1976 Aug; 175(2):524-33. PubMed ID: 8710
    [No Abstract]   [Full Text] [Related]  

  • 46. Lead and methyl mercury: effects of acute exposure on cytochrome P-450 and the mixed function oxidase system in the liver.
    Alvares AP; Leigh S; Cohn J; Kappas A
    J Exp Med; 1972 Jun; 135(6):1406-9. PubMed ID: 5025440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of cadmium, mercury and lead in vitro on hepatic microsomal mixed function oxidase and lipid peroxidation.
    Xiao GH; Wu JL; Liu YG
    J Tongji Med Univ; 1989; 9(2):81-5. PubMed ID: 2810436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic drug metabolism in rats: impairment in a dirty environment.
    Vesell ES; Lang CM; White WJ; Passananti GT; Tripp SL
    Science; 1973 Mar; 179(4076):896-7. PubMed ID: 4687785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of pargyline with rat hepatic microsomes.
    Valerino DM; Vesell ES; Stevens JT; Rudnick SL
    Pharmacology; 1978; 17(2):113-7. PubMed ID: 684076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversibility of hepatic changes caused by ethoxyquin.
    Parke DV; Rahim A; Walker R
    Biochem Pharmacol; 1974 Jul; 23(13):1871-6. PubMed ID: 4376401
    [No Abstract]   [Full Text] [Related]  

  • 51. Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.
    Boobis AR; Brodie MJ; Kahn GC; Fletcher DR; Saunders JH; Davies DS
    Br J Clin Pharmacol; 1980 Jan; 9(1):11-9. PubMed ID: 6766729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of fasting on monooxygenase system in rat liver in relation to age.
    Jahn F; Schiller F; Klinger W; Karge E
    Z Versuchstierkd; 1982; 24(5-6):281-90. PubMed ID: 6984993
    [No Abstract]   [Full Text] [Related]  

  • 53. [Changes in the monooxygenase activity of the mouse liver by the activity of high-molecular immunomodulators].
    Galkin BN; Filippova TO; Golovenko NIa
    Vopr Med Khim; 1983; 29(6):60-3. PubMed ID: 6199895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cadmium-thionein and the protection by cadmium against the nephrotoxicity of mercury.
    Webb M; Magos L
    Chem Biol Interact; 1976 Aug; 14(3-4):357-69. PubMed ID: 954150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of ellagic acid on xenobiotic metabolism by cytochrome P-450IIE1 and nitrosodimethylamine mutagenicity.
    Wilson T; Lewis MJ; Cha KL; Gold B
    Cancer Lett; 1992 Jan; 61(2):129-34. PubMed ID: 1730135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoquantification of cytochrome P-450 3A on rat paraffin-embedded liver tissue.
    Horsmans Y; Stevens M; Geubel A; Harvengt C; Rahier J
    Liver; 1992 Oct; 12(5):344-50. PubMed ID: 1447967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo protection by protein A of hepatic microsomal mixed function oxygenase system of cyclophosphamide-treated rats.
    Dohadwala M; Ray PK
    Cancer Chemother Pharmacol; 1985; 14(2):135-8. PubMed ID: 3971477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on the mechanism of cadmium-induced inhibition of the hepatic microsomal monooxygenase of the male rat.
    Means JR; Carlson GP; Schnell RC
    Toxicol Appl Pharmacol; 1979 Apr; 48(2):293-304. PubMed ID: 473179
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of growth hormone on cytochrome P-450j.
    Williams MT; Simonet LC
    Biochem Biophys Res Commun; 1988 Aug; 155(1):392-7. PubMed ID: 3415695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of triacetyloleandomycin, erythromycin and spiramycin on mono-oxygenase activity].
    Micheva M; Stoĭchev Ts
    Eksp Med Morfol; 1984; 23(1):28-33. PubMed ID: 6332004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.